Li Watsek's Stock Ratings

Cantor Fitzgerald Analyst

Li Watsek is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-22.9%

Smart Score

41.1%

Overall Average Return Percentile

10th

Number of Ratings

90
Buy NowGet Alert
03/14/2025TARABuy Now
Protara Therapeutics
$4.33—
Li Watsek41%
—Initiates → OverweightGet Alert
02/25/2025ASNDBuy Now
Ascendis Pharma
$164.6521.47%
Li Watsek41%
$170 → $200MaintainsOverweightGet Alert
02/11/2025ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$170 → $170ReiteratesOverweight → OverweightGet Alert
02/07/2025ARVNBuy Now
Arvinas
$8.36—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
01/31/2025ACRVBuy Now
Acrivon Therapeutics
$5.36—
Li Watsek41%
—Initiates → OverweightGet Alert
01/24/2025ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
01/13/2025IDYABuy Now
IDEAYA Biosciences
$18.47—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
12/18/2024ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
12/17/2024IDYABuy Now
IDEAYA Biosciences
$18.47—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
12/09/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—ReiteratesOverweight → OverweightGet Alert
11/26/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—Reiterates → OverweightGet Alert
11/21/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—Reiterates → OverweightGet Alert
11/19/2024AFMDBuy Now
Affimed
$0.92—
Li Watsek41%
—Reiterates → OverweightGet Alert
11/15/2024ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$170 → $170ReiteratesOverweight → OverweightGet Alert
11/12/2024ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—Reiterates → OverweightGet Alert
11/06/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—Reiterates → OverweightGet Alert
11/04/2024ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$170 → $170ReiteratesOverweight → OverweightGet Alert
10/07/2024RCUSBuy Now
Arcus Biosciences
$8.98—
Li Watsek41%
—Reiterates → OverweightGet Alert
10/03/2024RCUSBuy Now
Arcus Biosciences
$8.98—
Li Watsek41%
—Reiterates → OverweightGet Alert
09/16/2024ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$170 → $170ReiteratesOverweight → OverweightGet Alert
09/09/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—Reiterates → OverweightGet Alert
09/09/2024ARVNBuy Now
Arvinas
$8.36—
Li Watsek41%
—Reiterates → OverweightGet Alert
09/09/2024AFMDBuy Now
Affimed
$0.92—
Li Watsek41%
—Reiterates → OverweightGet Alert
09/09/2024YMABBuy Now
Y-mAbs Therapeutics
$4.54340.53%
Li Watsek41%
$20 → $20ReiteratesOverweight → OverweightGet Alert
09/09/2024ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$170 → $170ReiteratesOverweight → OverweightGet Alert
09/09/2024BCYCBuy Now
Bicycle Therapeutics
$9.57—
Li Watsek41%
—Reiterates → OverweightGet Alert
09/04/2024ASNDBuy Now
Ascendis Pharma
$164.653.25%
Li Watsek41%
$173 → $170MaintainsOverweightGet Alert
08/16/2024YMABBuy Now
Y-mAbs Therapeutics
$4.54340.53%
Li Watsek41%
→ $20Initiates → OverweightGet Alert
08/12/2024ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—Reiterates → OverweightGet Alert
08/09/2024KURABuy Now
Kura Oncology
$7.34—
Li Watsek41%
—Reiterates → OverweightGet Alert
08/09/2024RCUSBuy Now
Arcus Biosciences
$8.98—
Li Watsek41%
—Reiterates → OverweightGet Alert
07/31/2024ARVNBuy Now
Arvinas
$8.36—
Li Watsek41%
—Reiterates → OverweightGet Alert
05/29/2024ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—Reiterates → OverweightGet Alert
05/15/2024ASNDBuy Now
Ascendis Pharma
$164.655.07%
Li Watsek41%
$173 → $173ReiteratesOverweight → OverweightGet Alert
05/15/2024CRISBuy Now
Curis
$2.98—
Li Watsek41%
—Reiterates → OverweightGet Alert
05/03/2024ASNDBuy Now
Ascendis Pharma
$164.655.07%
Li Watsek41%
→ $173ReiteratesOverweight → OverweightGet Alert
04/18/2024ASNDBuy Now
Ascendis Pharma
$164.655.07%
Li Watsek41%
$173 → $173ReiteratesOverweight → OverweightGet Alert
04/12/2024ALXOBuy Now
ALX Oncology Holdings
$0.74—
Li Watsek41%
—Reiterates → OverweightGet Alert
04/09/2024VINCBuy Now
Vincerx Pharma
$0.71—
Li Watsek41%
—Reiterates → OverweightGet Alert
04/01/2024ASNDBuy Now
Ascendis Pharma
$164.655.07%
Li Watsek41%
$173 → $173ReiteratesOverweight → OverweightGet Alert
04/01/2024VINCBuy Now
Vincerx Pharma
$0.71—
Li Watsek41%
—Reiterates → OverweightGet Alert
04/01/2024CRVSBuy Now
Corvus Pharma
$4.69—
Li Watsek41%
—Reiterates → OverweightGet Alert
04/01/2024AFMDBuy Now
Affimed
$0.92—
Li Watsek41%
—Reiterates → OverweightGet Alert
02/06/2024ASNDBuy Now
Ascendis Pharma
$164.655.07%
Li Watsek41%
$152 → $173MaintainsOverweightGet Alert
12/20/2023ASNDBuy Now
Ascendis Pharma
$164.65-7.68%
Li Watsek41%
→ $152ReiteratesOverweight → OverweightGet Alert
11/22/2023SLSBuy Now
SELLAS Life Sciences Gr
$1.10172.75%
Li Watsek41%
→ $3ReiteratesOverweight → OverweightGet Alert
11/08/2023RCUSBuy Now
Arcus Biosciences
$8.98300.89%
Li Watsek41%
$46 → $36MaintainsOverweightGet Alert
11/08/2023BCYCBuy Now
Bicycle Therapeutics
$9.57579.21%
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
10/04/2023ALXOBuy Now
ALX Oncology Holdings
$0.742987.25%
Li Watsek41%
$18 → $23MaintainsOverweightGet Alert
09/25/2023AFMDBuy Now
Affimed
$0.92660.87%
Li Watsek41%
→ $70ReiteratesOverweight → OverweightGet Alert
09/15/2023ASNDBuy Now
Ascendis Pharma
$164.65-7.68%
Li Watsek41%
→ $152ReiteratesOverweight → OverweightGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$9.57579.21%
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
09/12/2023AFMDBuy Now
Affimed
$0.92660.87%
Li Watsek41%
→ $70ReiteratesOverweight → OverweightGet Alert
09/07/2023VINCBuy Now
Vincerx Pharma
$0.71607.51%
Li Watsek41%
→ $100ReiteratesOverweight → OverweightGet Alert
09/07/2023SLSBuy Now
SELLAS Life Sciences Gr
$1.10172.75%
Li Watsek41%
→ $3ReiteratesOverweight → OverweightGet Alert
09/07/2023PRTGBuy Now
Portage Biotech
$4.00175%
Li Watsek41%
→ $220ReiteratesOverweight → OverweightGet Alert
09/07/2023ONCTBuy Now
Oncternal Therapeutics
——
Li Watsek41%
→ $26ReiteratesNeutral → NeutralGet Alert
09/07/2023KURABuy Now
Kura Oncology
$7.34308.72%
Li Watsek41%
→ $30ReiteratesOverweight → OverweightGet Alert
09/07/2023FATEBuy Now
Fate Therapeutics
$0.95426.26%
Li Watsek41%
→ $5ReiteratesNeutral → NeutralGet Alert
09/07/2023CRVSBuy Now
Corvus Pharma
$4.69-14.71%
Li Watsek41%
→ $4ReiteratesOverweight → OverweightGet Alert
09/07/2023BCYCBuy Now
Bicycle Therapeutics
$9.57579.21%
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
09/07/2023ASNDBuy Now
Ascendis Pharma
$164.65-7.68%
Li Watsek41%
→ $152ReiteratesOverweight → OverweightGet Alert
09/07/2023ARVNBuy Now
Arvinas
$8.36737.1%
Li Watsek41%
→ $70ReiteratesOverweight → OverweightGet Alert
09/07/2023APTOBuy Now
Aptose Biosciences
$3.78905.29%
Li Watsek41%
→ $1140ReiteratesOverweight → OverweightGet Alert
09/07/2023AFMDBuy Now
Affimed
$0.92660.87%
Li Watsek41%
→ $70ReiteratesOverweight → OverweightGet Alert
08/31/2023PRTGBuy Now
Portage Biotech
$4.00175%
Li Watsek41%
→ $220ReiteratesOverweight → OverweightGet Alert
08/01/2023PRTGBuy Now
Portage Biotech
$4.00175%
Li Watsek41%
$320 → $220MaintainsOverweightGet Alert
07/21/2023KURABuy Now
Kura Oncology
$7.34308.72%
Li Watsek41%
→ $30ReiteratesOverweight → OverweightGet Alert
06/13/2023KURABuy Now
Kura Oncology
$7.34308.72%
Li Watsek41%
→ $30ReiteratesOverweight → OverweightGet Alert
06/12/2023APTOBuy Now
Aptose Biosciences
$3.78905.29%
Li Watsek41%
$180 → $1140MaintainsOverweightGet Alert
06/01/2023ASNDBuy Now
Ascendis Pharma
$164.65-7.68%
Li Watsek41%
→ $152ReiteratesOverweight → OverweightGet Alert
05/09/2023CRVSBuy Now
Corvus Pharma
$4.69-14.71%
Li Watsek41%
$2 → $4MaintainsOverweightGet Alert
05/04/2023FATEBuy Now
Fate Therapeutics
$0.95426.26%
Li Watsek41%
$8 → $5MaintainsNeutralGet Alert
04/28/2023ASNDBuy Now
Ascendis Pharma
$164.65-7.68%
Li Watsek41%
$142 → $152MaintainsOverweightGet Alert
04/04/2023ONCTBuy Now
Oncternal Therapeutics
——
Li Watsek41%
$80 → $26MaintainsOverweightGet Alert
02/27/2023BCYCBuy Now
Bicycle Therapeutics
$9.57673.25%
Li Watsek41%
→ $74Reiterates → OverweightGet Alert
01/31/2023ARVNBuy Now
Arvinas
$8.36976.27%
Li Watsek41%
→ $90Reiterates → OverweightGet Alert
12/22/2022ONCTBuy Now
Oncternal Therapeutics
——
Li Watsek41%
→ $80Initiates → OverweightGet Alert
11/04/2022FATEBuy Now
Fate Therapeutics
$0.954636.34%
Li Watsek41%
$98 → $45Assumes → OverweightGet Alert
08/12/2022NKTXBuy Now
Nkarta
$1.532383.66%
Li Watsek41%
$60 → $38MaintainsOverweightGet Alert
08/09/2022GBTBuy Now
Global Blood Therapeutics
——
Li Watsek41%
$75 → $68.5DowngradeOverweight → NeutralGet Alert
07/12/2022KURABuy Now
Kura Oncology
$7.34308.72%
Li Watsek41%
→ $30Initiates → OverweightGet Alert
06/28/2022SLSBuy Now
SELLAS Life Sciences Gr
$1.10445.5%
Li Watsek41%
$10 → $6MaintainsOverweightGet Alert
06/08/2022VINCBuy Now
Vincerx Pharma
$0.711032.02%
Li Watsek41%
$440 → $160MaintainsOverweightGet Alert
02/23/2022AFMDBuy Now
Affimed
$0.921204.35%
Li Watsek41%
→ $120Initiates → OverweightGet Alert
12/23/2021VINCBuy Now
Vincerx Pharma
$0.713437.57%
Li Watsek41%
→ $500Initiates → OverweightGet Alert
12/03/2021CRVSBuy Now
Corvus Pharma
$4.6970.58%
Li Watsek41%
$5 → $8MaintainsOverweightGet Alert
07/21/2021SLSBuy Now
SELLAS Life Sciences Gr
$1.101536.51%
Li Watsek41%
→ $18Initiates → OverweightGet Alert
05/27/2021CRVSBuy Now
Corvus Pharma
$4.69113.22%
Li Watsek41%
→ $10Initiates → OverweightGet Alert
11/25/2019GBTBuy Now
Global Blood Therapeutics
——
Li Watsek41%
$110 → $98MaintainsOverweightGet Alert